Abstract
The human body is a wonderful machine. Attempts have been made since time
immemorial to understand the functioning of this machine. The study of biology
has, over the years, moved on from being "in vivo"(within an organism)
to "in vitro" (outside an organism) and now biology is moving "in
silico" (using electronics and computers for biological research). The
study of life sciences has matured to the extent of making cloning of living
beings a reality.
Of late, the amount of information being churned out by the field of biology
has jumped manifold and now requires the extensive use of computers of the
management of this information. The field of bioinformatics that addresses this
need of biology has become an industry in its own right with the pharmaceutical
and biotechnology industries being dependent on it for their growth. The
bursting of the dotcom bubble in 2000 saw investors and venture capitalists
flocking to the biotechnology industry in general and bioinformatics in
particular.
With current revenues at around $ 840 million, Scope forecasts the
bioinformatics market to become more dominant in the future and increase to
around $1.82 billion by 2007. The growth rate is expected to stabilize at 17
percent per annum until 2007 as the sequencing of the human genome nears
completion in 2003. Over the past years, bioinformatics has gained acceptance
among number of markets especially in pharmaceutical, biotechnology, industrial
biotechnology and agricultural biotechnology (agbiotech).
The industry is highly fragmented and is seeing increased consolidation in
the form of alliances and acquisitions with the action being primarily
concentrated in the US and Europe. The overall competition has changed over the
past few years with IT super powers entering this industry as also Pharma
majors. This is expected to continue in the same way. Given this scenario, the
industry is witnessing a lot more competition, with companies entering into
strategic alliances to remain more competitive in the market. Issues such as
data management, data standardization and patents continue to dominate the
industry.
Major players in the bioinformatics industry include Accelrys, Compugen,
Celera Genomics, IBM Life Sciences Solutions, Incyte Genomics, LION Bioscience,
Structural Bioinformatics among others.
This report critically examines and provides insights into state of the
Global Bioinformatics Industry, as it exists today including market
segmentation, current market size and its forecast across segments, major
players, end user analysis, key industry drivers etc. Report also provides brief
profiles of some of the leading players in the market.
View Cart
